The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy.

Suppr

超能文献

作者信息

Coburn Lori A, Wise Paul E, Schwartz David A

机构信息

Inflammatory Bowel Disease Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.

出版信息

Dig Dis Sci. 2006 Nov;51(11):2045-7. doi: 10.1007/s10620-006-9452-2. Epub 2006 Sep 29.

DOI:10.1007/s10620-006-9452-2

PMID:17009112

Abstract

摘要

相似文献

The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy.

Dig Dis Sci. 2006 Nov;51(11):2045-7. doi: 10.1007/s10620-006-9452-2. Epub 2006 Sep 29.

Successful use of adalimumab (Humira) for Crohn's disease in pregnancy.

Inflamm Bowel Dis. 2006 Aug;12(8):827-8. doi: 10.1097/00054725-200608000-00020.

[Term pregnancy in a patient with Crohn's disease under treatment with adalimumab].

Gastroenterol Hepatol. 2005 Aug-Sep;28(7):435. doi: 10.1157/13077774.

Successfully multiple pregnancies in Crohn's disease under long-term treatment with adalimumab.

Acta Gastroenterol Belg. 2013 Jun;76(2):264-5.

Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature.

Inflamm Bowel Dis. 2010 Oct;16(10):1634-6. doi: 10.1002/ibd.21198.

Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease.

Gastroenterol Hepatol. 2018 Nov;41(9):576-582. doi: 10.1016/j.gastrohep.2018.06.010. Epub 2018 Jul 24.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000.

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.

Am J Gastroenterol. 2011 Feb;106(2):214-23; quiz 224. doi: 10.1038/ajg.2010.464. Epub 2010 Dec 14.

Adalimumab use in pregnancy.

Gut. 2005 Jun;54(6):890. doi: 10.1136/gut.2005.065417.

Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA.

Dis Colon Rectum. 2011 Jan;54(1):15-20. doi: 10.1007/DCR.0b013e3181fc9f04.

引用本文的文献

Chronic Antibiotic-Refractory Pouchitis: Management Challenges.

Clin Exp Gastroenterol. 2021 Jun 14;14:277-290. doi: 10.2147/CEG.S219556. eCollection 2021.

Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Intest Res. 2017 Jul;15(3):285-310. doi: 10.5217/ir.2017.15.3.285. Epub 2017 Jun 12.

Common Adverse Effects of Anti-TNF Agents on Gestation.

Obstet Gynecol Int. 2016;2016:8648651. doi: 10.1155/2016/8648651. Epub 2016 Dec 1.

Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.

World J Gastroenterol. 2015 Dec 21;21(47):13205-11. doi: 10.3748/wjg.v21.i47.13205.

Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child? - a systematic review.

BMC Gastroenterol. 2015 Feb 12;15:15. doi: 10.1186/s12876-015-0244-z.

Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding.

Transl Vis Sci Technol. 2012 Sep 21;1(2):6. doi: 10.1167/tvst.1.2.6. eCollection 2012.

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.

BMC Med. 2013 Jul 31;11:174. doi: 10.1186/1741-7015-11-174.

Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

World J Gastroenterol. 2013 May 7;19(17):2591-602. doi: 10.3748/wjg.v19.i17.2591.

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.

Clin Gastroenterol Hepatol. 2013 Mar;11(3):286-92; quiz e24. doi: 10.1016/j.cgh.2012.11.011. Epub 2012 Nov 28.

World J Gastroenterol. 2012 Jun 7;18(21):2600-8. doi: 10.3748/wjg.v18.i21.2600.

本文引用的文献

Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study.

Ann Rheum Dis. 2006 Jun;65(6):753-9. doi: 10.1136/ard.2005.044404. Epub 2005 Nov 24.

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease.

Aliment Pharmacol Ther. 2005 Mar 15;21(6):733-8. doi: 10.1111/j.1365-2036.2005.02405.x.

What next after infliximab?

Am J Gastroenterol. 2005 Jan;100(1):80-3. doi: 10.1111/j.1572-0241.2005.41716.x.

Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab.

Am J Gastroenterol. 2005 Jan;100(1):75-9. doi: 10.1111/j.1572-0241.2005.40647.x.

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.

Am J Gastroenterol. 2004 Dec;99(12):2385-92. doi: 10.1111/j.1572-0241.2004.30186.x.

A pilot study of adalimumab in infliximab-allergic patients.

Inflamm Bowel Dis. 2004 Jul;10(4):333-8. doi: 10.1097/00054725-200407000-00002.

An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.

Am J Gastroenterol. 2004 Oct;99(10):1984-9. doi: 10.1111/j.1572-0241.2004.40462.x.

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.

Clin Ther. 2003 Jun;25(6):1700-21. doi: 10.1016/s0149-2918(03)80164-9.

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

Arthritis Rheum. 2003 Jan;48(1):35-45. doi: 10.1002/art.10697.

Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials.

Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii70-3. doi: 10.1136/ard.61.suppl_2.ii70.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验